- Home
- HFFG vs RCEL Comparison
HFFG vs RCEL Comparison
Compare HFFG & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFFG
- RCEL
- Stock Information
- Founded
- HFFG 1997
- RCEL N/A
- Country
- HFFG United States
- RCEL United States
- Employees
- HFFG N/A
- RCEL N/A
- Industry
- HFFG Food Distributors
- RCEL Medical/Dental Instruments
- Sector
- HFFG Consumer Discretionary
- RCEL Health Care
- Exchange
- HFFG Nasdaq
- RCEL Nasdaq
- Market Cap
- HFFG 208.3M
- RCEL 170.8M
- IPO Year
- HFFG N/A
- RCEL N/A
- Fundamental
- Price
- HFFG $3.79
- RCEL $5.89
- Analyst Decision
- HFFG
- RCEL Strong Buy
- Analyst Count
- HFFG 0
- RCEL 4
- Target Price
- HFFG N/A
- RCEL $17.25
- AVG Volume (30 Days)
- HFFG 156.2K
- RCEL 347.9K
- Earning Date
- HFFG 05-12-2025
- RCEL 05-08-2025
- Dividend Yield
- HFFG N/A
- RCEL N/A
- EPS Growth
- HFFG N/A
- RCEL N/A
- EPS
- HFFG N/A
- RCEL N/A
- Revenue
- HFFG $1,204,441,000.00
- RCEL $71,661,000.00
- Revenue This Year
- HFFG $4.77
- RCEL $59.50
- Revenue Next Year
- HFFG $3.97
- RCEL $28.89
- P/E Ratio
- HFFG N/A
- RCEL N/A
- Revenue Growth
- HFFG 4.71
- RCEL 41.35
- 52 Week Low
- HFFG $1.70
- RCEL $5.46
- 52 Week High
- HFFG $4.93
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- HFFG 44.89
- RCEL 25.13
- Support Level
- HFFG $3.81
- RCEL $5.46
- Resistance Level
- HFFG $4.29
- RCEL $6.38
- Average True Range (ATR)
- HFFG 0.21
- RCEL 0.43
- MACD
- HFFG -0.05
- RCEL -0.10
- Stochastic Oscillator
- HFFG 9.68
- RCEL 5.33
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.